Literature DB >> 26545494

Roles of LIM kinases in central nervous system function and dysfunction.

H Cuberos1, B Vallée2, P Vourc'h3, J Tastet4, C R Andres3, H Bénédetti2.   

Abstract

LIM kinase 1 (LIMK1) and LIM kinase 2 (LIMK2) regulate actin dynamics by phosphorylating cofilin. In this review, we outline studies that have shown an involvement of LIMKs in neuronal function and we detail some of the pathways and molecular mechanisms involving LIMKs in neurodevelopment and synaptic plasticity. We also review the involvement of LIMKs in neuronal diseases and emphasize the differences in the regulation of LIMKs expression and mode of action. We finally present the existence of a cofilin-independent pathway also involved in neuronal function. A better understanding of the differences between both LIMKs and of the precise molecular mechanisms involved in their mode of action and regulation is now required to improve our understanding of the physiopathology of the neuronal diseases associated with LIMKs.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  LIM kinase 1; LIM kinase 2; Neurodegenerative disease; Neurodevelopmental disease; Neuronal function

Mesh:

Substances:

Year:  2015        PMID: 26545494     DOI: 10.1016/j.febslet.2015.10.032

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  21 in total

1.  MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1.

Authors:  Dengfeng Li; Hongming Song; Tianqi Wu; Dan Xie; Jiashu Hu; Junyong Zhao; Qiang Shen; Lin Fang
Journal:  Mol Cell Biochem       Date:  2017-11-29       Impact factor: 3.396

2.  LIM kinase 1 acts as a profibrotic mediator in permanent atrial fibrillation patients with valvular heart disease.

Authors:  Qinhua Chen; Ryan C Gimple; Guannan Li; Jianzhou Chen; Han Wu; Ran Li; Jun Xie; Biao Xu
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

Review 3.  Differential expression of cytoskeletal regulatory factors in the adolescent prefrontal cortex: Implications for cortical development.

Authors:  Lauren P Shapiro; Ryan G Parsons; Anthony J Koleske; Shannon L Gourley
Journal:  J Neurosci Res       Date:  2016-10-13       Impact factor: 4.164

4.  Augmented noncanonical BMP type II receptor signaling mediates the synaptic abnormality of fragile X syndrome.

Authors:  Risa Kashima; Sougata Roy; Manuel Ascano; Veronica Martinez-Cerdeno; Jeanelle Ariza-Torres; Sunghwan Kim; Justin Louie; Yao Lu; Patricio Leyton; Kenneth D Bloch; Thomas B Kornberg; Paul J Hagerman; Randi Hagerman; Giorgio Lagna; Akiko Hata
Journal:  Sci Signal       Date:  2016-06-07       Impact factor: 8.192

5.  A Loss or a Gain, Is It Not All the Same?

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2016-02-05

6.  Suppression of LIM Kinase 1 and LIM Kinase 2 Limits Glioblastoma Invasion.

Authors:  Joseph Chen; Badriprasad Ananthanarayanan; Kelsey S Springer; Kayla J Wolf; Sharon M Sheyman; Vivien D Tran; Sanjay Kumar
Journal:  Cancer Res       Date:  2019-10-22       Impact factor: 12.701

Review 7.  LIM Kinases, Promising but Reluctant Therapeutic Targets: Chemistry and Preclinical Validation In Vivo.

Authors:  Rayan Berabez; Sylvain Routier; Hélène Bénédetti; Karen Plé; Béatrice Vallée
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

Review 8.  Protein kinases: master regulators of neuritogenesis and therapeutic targets for axon regeneration.

Authors:  Sarah A Bennison; Sara M Blazejewski; Trevor H Smith; Kazuhito Toyo-Oka
Journal:  Cell Mol Life Sci       Date:  2019-10-28       Impact factor: 9.261

9.  Semaphorin3F Drives Dendritic Spine Pruning Through Rho-GTPase Signaling.

Authors:  Bryce W Duncan; Vishwa Mohan; Sarah D Wade; Young Truong; Alexander Kampov-Polevoi; Brenda R Temple; Patricia F Maness
Journal:  Mol Neurobiol       Date:  2021-04-15       Impact factor: 5.590

Review 10.  Neuronal Cytoskeleton in Intellectual Disability: From Systems Biology and Modeling to Therapeutic Opportunities.

Authors:  Carla Liaci; Mattia Camera; Giovanni Caslini; Simona Rando; Salvatore Contino; Valentino Romano; Giorgio R Merlo
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.